Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

Summary

This phase II trial compares the effect of adding radiation therapy to the usual maintenance therapy with Serplulimab versus Serplulimab alone in patients who have already received Serplulimab plus chemotherapy for the treatment of extensive stage small cell lung cancer .

Timeline

Start

2023-10-18

Primary completion

2024-12-31

Completion

2025-12-31

Drugs

Indications